One of the stocks to have come into focus in recent days is that of Halberd Corporation (OTCMKTS:HALB). Over the course of the past week, the stock has rallied strongly and gained as much as 100%. Considering the gains made by the company, it could be a good idea for investors to perhaps take a closer look at the company.
Bullish comments from the Chief Executive Officer of a company are always welcome and hence, the comments from Halberd CEO Bill Hartman last week must have been music to the ears of investors.
Hartman went on The Stock Day Podcast and spoke about a range of developments at Halberd. He stated that after signing up for Arizona State University (ASU) as a university partner, the company has successfully developed an antibody against COVID 19. He revealed that the company is going to file for patents for two of those.
In addition to that, Hartman also spoke about the company’s stock price. He stated that the stock price is currently low because of the low market cap of Halberd. That being said, he went on to point out that Halberd also has a low float, and more importantly, the company is debt-free.
Additionally, he stated that Halberd has opened operations in South America and has access to the market in Asia as well. Hartman noted that the company’s products have the potential of finding a worldwide customer base.
Patent Application with ASU
However, that is not all. There was another significant development last week for Halberd that added to the positive momentum in the stock.
The company announced that it jointly initiated a patent application with ASU for its COVID 19 antibody. It is a significant development for the company and the rally in the stock did not come as a surprise.
ASU and Halberd conducted the research into the new antibody and it was the latter’s intellectual property that was deployed into the whole process. The antibody, that has been engineered, can help in the quick discovery of COVID 19 in an individual’s urine, blood, and saliva among others.
In addition to that, it has also been pointed out that the antibody could also help in discovering the COVID 19 virus on surfaces like door handles and mobile phones among others. As a new week begins, it is likely that the Halberd stock is going to be in focus among investors.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.